000 01778 a2200541 4500
005 20250513214730.0
264 0 _c20000907
008 200009s 0 0 eng d
022 _a0085-2538
024 7 _a10.1046/j.1523-1755.2000.00219.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWolf, W C
245 0 0 _aHuman tissue kallikrein gene delivery attenuates hypertension, renal injury, and cardiac remodeling in chronic renal failure.
_h[electronic resource]
260 _bKidney international
_cAug 2000
300 _a730-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdenoviridae
_xgenetics
650 0 4 _aAnimals
650 0 4 _aBlood Pressure
650 0 4 _aBlood Urea Nitrogen
650 0 4 _aCardiomegaly
_xpathology
650 0 4 _aCyclic GMP
_xurine
650 0 4 _aFibrosis
_xprevention & control
650 0 4 _aGene Expression
_xphysiology
650 0 4 _aGenetic Therapy
650 0 4 _aHumans
650 0 4 _aHypertension, Renal
_xpathology
650 0 4 _aInjections, Intravenous
650 0 4 _aKidney Failure, Chronic
_xpathology
650 0 4 _aKinins
_xurine
650 0 4 _aMale
650 0 4 _aNephrectomy
650 0 4 _aNitrates
_xurine
650 0 4 _aNitrites
_xurine
650 0 4 _aRats
650 0 4 _aRats, Wistar
650 0 4 _aRenal Circulation
650 0 4 _aTissue Kallikreins
_xgenetics
650 0 4 _aVascular Resistance
650 0 4 _aVasodilation
_xphysiology
650 0 4 _aVentricular Remodeling
700 1 _aYoshida, H
700 1 _aAgata, J
700 1 _aChao, L
700 1 _aChao, J
773 0 _tKidney international
_gvol. 58
_gno. 2
_gp. 730-9
856 4 0 _uhttps://doi.org/10.1046/j.1523-1755.2000.00219.x
_zAvailable from publisher's website
999 _c10865791
_d10865791